A massive analysis recently published in the journal Aging Cell revealed that rapamycin — the immunosuppressant drug turned ...

Metformin use may enhance progression-free survival (PFS) in patients receiving first-line systemic therapy for patients with ...

Rapamycin may match the benefits of eating less. Scientists are now exploring its potential to support healthy aging. The ...

“Metformin is a widely used, first-line medication for treating type 2 diabetes.It belongs to a class of drugs called biguanides,” says Hans J. Schmidt, M.D., chief of bariatric surgery and ...

A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction ...

Metformin is a well-known medicine used to help people with type 2 diabetes control their blood sugar. But new research from ...

The anti-aging drug Rapamycin has the same life-extending effect as eating less, according to new research from the ...

Hisu lee. For centuries, humans have searched for ways to extend life. Alchemists never found the philosopher’s stone, but ...

Animal studies suggest rapamycin is as effective as long-term fasting ...

Semaglutide is linked to a reduced risk for Alzheimer’s disease-related dementia in patients with diabetes vs other antidiabetic drugs, a new study suggests.

That makes rapamycin one of the most exciting leads for new anti-ageing therapies. Ageing might not be considered a disease, but it is a risk factor behind many diseases from cancer to dementia. If we ...

Metformin and lifestyle intervention was associated with delayed type 2 diabetes onset and slower diabetes progression than placebo.